Centene (CNC), HCA Healthcare (HCA) and Molina Healthcare (MOH) are among the worst-performing stocks in the S&P 500 Monday after President Donald Trump suggested federal health care money should circ
Here is how Arcosa (ACA) and Babcock International Group PLC (BCKIY) have performed compared to their sector so far this year.
Arcosa (ACA) possesses solid growth attributes, which could help it handily outperform the market.
Arcosa, Inc. ( ACA ) Q3 2025 Earnings Call October 31, 2025 8:30 AM EDT Company Participants Erin Drabek - VP of Investor Relations Antonio Carrillo - President, CEO & Director Gail Peck - Chief Finan
While the top- and bottom-line numbers for Arcosa (ACA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare
Arcosa (ACA) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $0.91 per share a year ago.
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for th
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcosa (NYSE: ACA - Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Arcosa to post earnings of $1.31 per share and revenu
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the
Tariffs, inflation and housing headwinds weigh on the industry. Yet, AWI, FTDR, ACA and ECG look primed to benefit from infrastructure and innovation tailwinds.
Oscar Health, an ACA marketplace pure play, is leading the way.
Arcosa remains a soft 'buy' due to attractive valuation, ongoing revenue growth, and solid industry catalysts despite recent underperformance vs. the S&P 500. ACA's revenue growth is driven by strateg

Oscar Health: Buy Now On ACA Concerns

10:49am, Thursday, 25'th Sep 2025
Oscar Health (OSCR) remains up 31% YTD as investors watch for developments on ACA enhanced subsidies, a key driver for its marketplace business. Policy risk looms with potential ACA subsidy expiration

Arcosa Announces Dual Listing on NYSE Texas

04:15pm, Wednesday, 24'th Sep 2025
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA), a provider of infrastructure-related products and solutions, announced today the dual listing of its common stock on NYSE Texas, the newly launched f
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE